Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
12 hedge funds and large institutions have $176K invested in Aoxing Pharmaceutical Company Inc. in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.
54% more capital invested
Capital invested by funds: $114K → $176K (+$62K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$97.5K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$21.7K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$15.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$15K |
| 2 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$9.22K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6.83K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.76K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$3.36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $80K | +$97.5K | +145,029 | New |
|
2
Bank of New York Mellon
New York
| $28K | -$366 | -544 | -1% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $18K | +$21.7K | +32,319 | New |
|
4
Barclays
London,
United Kingdom
| $14K | – | – | – |
|
|
PAM
5
Panagora Asset Management
Boston,
Massachusetts
| $13K | +$15.9K | +23,637 | New |
|
|
EWM
6
Evercore Wealth Management
New York
| $7K | – | – | – |
|
|
7
Citadel Advisors
Miami,
Florida
| $6K | -$6.83K | -10,156 | -50% |
|
|
FWM
8
Focused Wealth Management
Newburgh,
New York
| $4K | -$9.22K | -13,715 | -65% |
|
|
9
UBS Group
Zurich,
Switzerland
| $3K | -$3.76K | -5,595 | -56% |
|
|
10
Creative Planning
Overland Park,
Kansas
| $3K | -$3.36K | -5,000 | -50% |
|
|
BFA
11
BlackRock Fund Advisors
San Francisco,
California
| – | -$15K | -23,080 | Closed |
|
AXN Hedge Fund Activity: Q3 2016 in Review
12 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q3 2016, worth a combined $176K — up 54% from $114K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AXN positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $97.5K. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $15K sold.
- 12 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q3 2016, up from 11 in Q2 2016.
- Funds reported $176K of Aoxing Pharmaceutical Company Inc. stock for Q3 2016, up 54% quarter-over-quarter.
- 3 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q3 2016 and 2 closed out, a net change of +1 holder.
- The largest Aoxing Pharmaceutical Company Inc. buyer in Q3 2016 was Susquehanna International Group, an estimated $97.5K added.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q3 2016 was BlackRock Fund Advisors, an estimated $15K sold.
Based on aggregated 13F filings for Q3 2016.